Pharma Focus Asia

WACKER Announces Plans to Invest in Amsterdam Biotech Site

Introduction:

WACKER has recently announced investment plans for its production facilities of biologics, LMPs (live microbial products) and vaccines located at Amsterdam site, at a mid-double-digit million-euro amount.

Features:

The investment features construction of a new fermentation line with a volume of 1,500 liters and setting up of new cleanroom structures in the 270-liter fermentation line at the biotech site in Amsterdam. In addition, the existing clean rooms are successively re-equipped and renovated with state-of-the-art equipment.

After certain developments made at the new biotech site, the new 1,500-liter line will replace an existing line of the same volume capacity. Hence, with the introduction to new structures, new equipment and new fermentation lines makes the production facilities faster.

Another major improvement that is planned is the supply of new utilities, such as water for injection, which indeed will complement the plant for the production of new classes of actives, such as pDNA and mRNA-based vaccines.

Specifications:

NameWACKER
TypeNew Construction & Expansion
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?